Answers are grounded in this paper and cite their sources.
Introduction:The role of immune activation in psychiatric disorders has attracted consid erable attention in the past two decades and has become the beginning of a new era for the treatment of psychiatric diseases.Neuroinflammation has been recognized as a key mecha nism in the onset and progression of various neurodegenerative diseases, including Alzhei mer's disease, Parkinson's disease, and multiple sclerosis.In addition, chronic inflammation caused by immune cells, especially microglia, plays a significant role in many psychiatric diseases such as autism, chronic stress, anxiety disorders, and posttraumatic stress disor der (PTSD).Epidemiological studies have demonstrated that PTSD is significantly associ ated with an increased risk of diseases characterized by immune dysregulation and chron ic neuroinflammation, often induced by microglial activation and excessive production of inflammatory cytokines.In this regard, several studies have reported that individuals with PTSD exhibit elevated levels of proinflammatory markers, such as interleukin1 beta, in terleukin6, tumor necrosis factoralpha, and Creactive protein compared to healthy sub jects.Neuroinflammation is not only associated with PTSD, but may also play an import ant role in its pathogenesis and pathophysiology.Microglia, as innate immune cells in the brain, play an important role in maintaining the homeostasis of the central nervous sys tem.However, excessive activation of neurotoxic microglia leads to neuroinflammation, resulting in damage to healthy brain tissue.Consequently, understanding microglial func tion provides a promising avenue for the treatment of psychiatric disorders, such as PTSD.Conclusion: This review article describes the role of microglial pathophysiology in the development and progression of PTSD, with a focus on neuroinflammatory mechanisms.
No takes yet. Share an insight, caveat, or question.
Basirat et al. (2025) studied this question.